This is CE mark trial to prove device suitability for intended use - no drug therapy, no patient specific state monitoring sought Not Applicable
Conditions
Interventions
The purpose of the study is to provide evidence that after training patients are able to perform a finger prick and add a blood droplet to a cartridge for successful and accurate measurement of white
Sponsors
Philips Healthcare Incubator (Home Clinical Monitoring) (Netherlands)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients attending clinics within St Thomas' Hospital, London, UK 2. Aged 18 - 85
Exclusion criteria
Exclusion criteria: Leukaemic patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To prove the device can be CE marked for its intended use | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
United Kingdom
Outcome results
None listed